Optimization of the Chemical Composition of Cast Iron Used for Casting Ball Bearing Grinding Disks

The chemical composition of cast iron used for casting ball bearing machining disks was varied to optimize the properties such as castability, hardenability, and durability in ball machining. The cast iron characteristics were most strongly dependent on the Ni content and the carbon saturation degree, So. This paper describes the types of test specimens, the working conditions, and the experimental results. The increase of the degree of carbon saturation reduces the tendency to form shrinkholes in the castings. The decrease in the Ni content negatively affects the final hardening treatment. A way to control solidification defects in cast iron, by reducing the Ni content, has been verified on cast disks.     

The clonal and mutational evolution spectrum of primary triple-negative breast cancers

Primary triple-negative breast cancers (TNBCs), a tumour type defined by lack of oestrogen receptor, progesterone receptor and ERBB2 gene amplification, represent approximately 16% of all breast cancers. Here we show in 104 TNBC cases that at the time of diagnosis these cancers exhibit a wide and continuous spectrum of genomic evolution, with some having only a handful of coding somatic aberrations in a few pathways, whereas others contain hundreds of coding somatic mutations. High-throughput RNA sequencing (RNA-seq) revealed that only approximately 36% of mutations are expressed. Using deep re-sequencing measurements of allelic abundance for 2,414 somatic mutations, we determine for the first time-to our knowledge-in an epithelial tumour subtype, the relative abundance of clonal frequencies among cases representative of the population. We show that TNBCs vary widely in their clonal frequencies at the time of diagnosis, with the basal subtype of TNBC showing more variation than non-basal TNBC. Although p53 (also known as TP53), PIK3CA and PTEN somatic mutations seem to be clonally dominant compared to other genes, in some tumours their clonal frequencies are incompatible with founder status. Mutations in cytoskeletal, cell shape and motility proteins occurred at lower clonal frequencies, suggesting that they occurred later during tumour progression. Taken together, our results show that understanding the biology and therapeutic responses of patients with TNBC will require the determination of individual tumour clonal genotypes.